Amundi Index MSCI Europe UCITS ETF DR GBP is a equity ETF from Amundi tracking the MSCI Europe index through physical replication. Domiciled in Luxembourg and launched in 2016, the fund manages about 4.1 bn € and charges a TER of 0.12% — 12 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Amundi Index MSCI Europe UCITS ETF DR GBP competes with 8 other products on the same index (MSCI Europe): it ranks 4th by fund size and 2nd by ongoing cost, with a TER of 0.12% against a group median of 0.12%. It has been listed since 2016, 10 years of track record.
On a €10,000 investment the TER costs 12 € a year. The cheapest of the group is HSBC MSCI Europe UCITS ETF EUR at 0.10%, or 10 € on the same amount: a difference of 2 € every year, roughly 20 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 21.7% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in GBP. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 5.4% |
| HSBC Holdings PLC | 2.3% |
| Roche Holding AG | 2.1% |
| Novartis AG | 2.0% |
| AstraZeneca PLC | 2.0% |
| Nestle S.A. | 1.9% |
| Siemens Aktiengesellschaft | 1.7% |
| Shell plc | 1.6% |
| Banco Santander S.A. | 1.4% |
| Allianz SE VNA O.N. | 1.3% |
| Borsa Italiana | CEU2 | EUR |
| London Stock Exchange | CEG2 | GBX |
| London Stock Exchange | CEU2 | USD |
| Euronext Paris | CEU2 | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.